About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 767496, 6 pages
http://dx.doi.org/10.1155/2013/767496
Clinical Study

The Incidence of Hypogonadotropic Hypogonadism in Type 2 Diabetic Men in Polish Population

1Department of Internal Diseases, Diabetology and Endocrinology, Warsaw Medical University, Kondratowicza Street 8, 03-242 Warsaw, Poland
2Department of Endocrinology, Medical Centre for Postgraduate Education, Warsaw, Poland

Received 30 April 2013; Revised 27 August 2013; Accepted 16 September 2013

Academic Editor: Gabriel F. Anhe

Copyright © 2013 Michał Rabijewski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Kim, Y. Rolland, O. Cepeda, J. K. Gammack, and J. E. Morley, “Diabetes mellitus in older men,” The Aging Male, vol. 9, no. 3, pp. 139–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Polakowska and W. Piotrowski, “Incidence of diabetes in the Polish population: results of the multicenter Polish population health status study—WOBASZ,” Polskie Archiwum Medycyny Wewnetrznej, vol. 121, no. 5, pp. 156–163, 2011. View at Scopus
  3. K. Zatońska, R. Ilow, B. Regulska-Ilow et al., “Prevalence of diabetes mellitus and IFG in the prospective cohort ‘PONS’ study-baseline assessment,” Annals of Agricultural and Environmental Medicine, vol. 18, no. 2, pp. 265–269, 2011. View at Scopus
  4. P. Dandona and S. Dhindsa, “Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 9, pp. 2643–2651, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Grossmann, M. C. Thomas, S. Panagiotopoulos et al., “Low testosterone levels are common and associated with insulin resistance in men with diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1834–1840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Selvin, M. Feinleib, L. Zhang et al., “Androgens and diabetes in men: Results from the Third National Health and Nutrition Examination Survey (NHANES III),” Diabetes Care, vol. 30, no. 6, pp. 234–238, 2007. View at Scopus
  7. S. Dhindsa, M. G. Miller, C. L. McWhirter et al., “Testosterone concentrations in diabetic and nondiabetic obese men,” Diabetes Care, vol. 33, pp. 1186–1192, 2010.
  8. S. Dhindsa, S. Prabhakar, M. Sethi, A. Bandyopadhyay, A. Chaudhuri, and P. Dandona, “Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5462–5468, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Tomar, S. Dhindsa, A. Chaudhuri, P. Mohanty, R. Garg, and P. Dandona, “Contrasting testosterone concentrations in type 1 and type 2 diabetes,” Diabetes Care, vol. 29, no. 5, pp. 1120–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Pitteloud, A. A. Dwyer, S. DeCruz et al., “The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 7, pp. 2686–2692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Tajar, G. Forti, T. W. O'Neill et al., “Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European male ageing study,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 4, pp. 1810–1818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Laughlin, E. Barrett-Connor, and J. Bergstrom, “Low serum testosterone and mortality in older men,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 1, pp. 68–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Wang, E. Nieschlag, R. Swerdloff et al., “ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males,” International Journal of Impotence Research, vol. 21, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Rabijewski, L. Papierska, J. Kozakowski, et al., “The high prevalence of testosterone deficiency in population of Polish men over 65 years with erectile dysfunctions,” The Aging Male, vol. 15, pp. 258–262, 2012.
  15. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 35, supplement 1, pp. 1–8, 2012.
  16. A. Vermeulen, L. Verdonck, and J. M. Kaufman, “A critical evaluation of simple methods for the estimation of free testosterone in serum,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 10, pp. 3666–3672, 1999. View at Scopus
  17. E. L. Rhoden, E. P. Ribeiro, C. Teloken, and C. A. V. Souto, “Diabetes mellitus is associated with subnormal serum levels of free testosterone in men,” BJU International, vol. 96, no. 6, pp. 867–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Corona, E. Mannucci, L. Petrone et al., “Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic,” International Journal of Impotence Research, vol. 18, no. 2, pp. 190–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Kapoor, H. Aldred, S. Clark, K. S. Channer, and T. H. Jones, “Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity,” Diabetes Care, vol. 30, no. 4, pp. 911–917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. E. Laaksonen, L. Niskanen, K. Punnonen et al., “Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men,” Diabetes Care, vol. 27, no. 5, pp. 1036–1041, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Mogri, S. Dhindsa, T. Quattrin, et al., “Testosterone concentrations in young pubertal and post-pubertal obese males,” Clinical Endocrinology, vol. 78, no. 4, pp. 593–599, 2013.
  22. D. E. Laaksonen, L. Niskanen, K. Punnonen et al., “Sex hormones, inflammation and the metabolic syndrome: a population-based study,” European Journal of Endocrinology, vol. 149, no. 6, pp. 601–608, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-P. Després, B. Lamarche, P. Mauriège et al., “Hyperinsulinemia as an independent risk factor for ischemic heart disease,” The New England Journal of Medicine, vol. 334, no. 15, pp. 952–957, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. G. B. Phillips, T. Jing, and S. B. Heymsfield, “Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction,” Metabolism, vol. 52, no. 6, pp. 784–790, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. E. C. Tsai, A. M. Matsumoto, W. Y. Fujimoto, and E. J. Boyko, “Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat,” Diabetes Care, vol. 27, no. 4, pp. 861–868, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. R. K. Stellato, H. A. Feldman, O. Hamdy, E. S. Horton, and J. B. Mckinlay, “Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts Male Aging Study,” Diabetes Care, vol. 23, no. 4, pp. 490–494, 2000. View at Scopus
  27. E. L. Ding, Y. Song, V. S. Malik, and S. Liu, “Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis,” Journal of the American Medical Association, vol. 295, no. 11, pp. 1288–1299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. H.-Y. Lin, Q. Xu, S. Yeh, R.-S. Wang, J. D. Sparks, and C. Chang, “Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor,” Diabetes, vol. 54, no. 6, pp. 1717–1725, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Kapoor, C. J. Malkin, K. S. Channer, and T. H. Jones, “Androgens, insulin resistance and vascular disease in men,” Clinical Endocrinology, vol. 63, no. 3, pp. 239–250, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Bhasin, G. R. Cunningham, F. J. Hayes et al., “Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 6, pp. 1995–2010, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Rabijewski, M. Kubuj, and S. Zgliczynski, “The efficacy and safety of testosterone replacement therapy in elderly men with hypogonadism,” Polish Journal of Endocrinology, vol. 3, pp. 293–300, 2003.
  32. D. Kapoor, E. Goodwin, K. S. Channer, and T. H. Jones, “Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes,” European Journal of Endocrinology, vol. 154, no. 6, pp. 899–906, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Boyanov, Z. Boneva, and V. G. Christov, “Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency,” The Aging Male, vol. 6, no. 1, pp. 1–7, 2003. View at Scopus